End-of-day quote
Taiwan S.E.
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
2,185
TWD
|
-0.46%
|
|
+3.07%
|
-23.87%
|
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
|
1st Jan change
|
Capi.
|
Investor Rating
|
ESG Refinitiv
|
---|
| -23.87% | 8.94B | | B- | | +0.95% | 1.47B | |
-
| | -24.38% | 1.25B | |
-
| | -34.88% | 1.23B | |
-
| | +58.52% | 999M |
-
|
-
| | -27.37% | 987M |
-
|
-
| | +16.47% | 880M |
-
|
-
| | +19.55% | 833M | |
-
| | -14.87% | 641M | |
-
| | -33.12% | 576M |
-
|
-
|
4 months Revenue revision
Divergence of analysts' opinions
Divergence of Target Price
|